A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Clinical Investigation Training Program Bookmark and Share

Clinical Investigation Training Program

The Clinical Investigation Training Program (CITP) is committed to addressing the critical need for formal training and advancement in clinical research, as well as increasing the quantity, and more importantly, quality of well trained clinical investigators. The ultimate goal is to provide clinical research education, guided by apatient-centered philosophy, which will have a significant impact on cancer and other life-threatening diseases.
 
City of Hope's Clinical Investigation Training Program (CITP) is dedicated to a core group of objectives. Among these are:
  • Provide high-quality, multidisciplinary services to our scholars
     
  • Address the critical need for formal training and advancement in clinical investigation as well as increase the quantity and, more importantly, quality of well-trained clinical investigators.
     
  • Facilitate, through intensive mentoring, the transition fromscholar to independent clinical investigator
     
  • Bring City of Hope scientists and clinicians closer together to facilitate the bench-to-bedside continuum
     

CITP Core Curriculum

Core Curriculum
The City of Hope Clinical Investigation Training Program (CITP) is a yearlong (4 quarter) curriculum designed to present the principles and practices used in the planning and execution of patient-oriented research including principles and methods in biostatistics, clinical epidemiology, clinical trial development, ethics, and good clinical practices of research. Each course can be taken in any order throughout the year. A certificate in Clinical Research is awarded to scholars successfully completing the Program.
 
Methodology in Observational Studies CI510 (Fall) - Design & Analysis of Observational Research
Provides an overview of epidemiologic methods and their application to observational studies. Scholars will develop/enhance their ability to evaluate observational studies, including the adequacy of study design and the validity of stated conclusions. Scholars will also acquire the necessary conceptual frameworkto plan an observational study in collaboration with a statistical co-investigator.
 
Methodology in Therapeutic Studies CI520 (Winter) - Design& Analysis of Intervention Research
Provides anintroduction to the concepts, theory, and application of interventional clinical trials and the statistics commonly used to analyze these studies. This is a Biostatistics/Clinical Investiagation course that builds on basic background of biostatistics, and introductory clinical trials. This course will explore the fundamentals of clinical investigation including: the definition of study goals, application and theory, objectives and outcomes, trial design and outcome monitoring, and result reporting, as well as a brief review of the underlying statistical methods.
 
Study Design & Development CI530 (Spring) - Design & Development of Human Subject Research
Provides a review of the clinical study process as well as continued instruction in trial development. Scholars will experience the "Nuts and Bolts" of a clinical study, from submission, to committee review, activation, and monitoring. Each scholar will actively participate in the submission of a "mock" clinical protocol. The proper design, conduct, and analysis of a clinical study are imperative to the well being of each participant as well as the integrity of the study results. Responsible conduct of research and good clinical practice will be emphasized throughout the course as they are the cornerstones to an effective and efficient clinical study.
 
Scientific Writing & Evaluation CI550/1 (Summer)
This course will alternate yearly, and address topics in protocol writing and development (CI550) and career development awards (CI551). The emphasis of CI550 will be on developing a complete and feasible protocol leading to an efficient, effective clinical study. The classes will combine didactic instruction with small group discussions and "hands on" learning. The emphasis of CI551 will be on early career advancement, competitivegrant writing, and literature evaluation. This course will focus on developing a fundable, career development award suitable for peer review. Evaluations will be through oral presentations and a completed career development application.
 

CITP Contact Information

Lina Mayorga, M.P.H., C.H.E.S.
Graduate Medical Educaton & Clinical Training
Direct: 626-218-8714

Clinical Investigation Training Program

Clinical Investigation Training Program

The Clinical Investigation Training Program (CITP) is committed to addressing the critical need for formal training and advancement in clinical research, as well as increasing the quantity, and more importantly, quality of well trained clinical investigators. The ultimate goal is to provide clinical research education, guided by apatient-centered philosophy, which will have a significant impact on cancer and other life-threatening diseases.
 
City of Hope's Clinical Investigation Training Program (CITP) is dedicated to a core group of objectives. Among these are:
  • Provide high-quality, multidisciplinary services to our scholars
     
  • Address the critical need for formal training and advancement in clinical investigation as well as increase the quantity and, more importantly, quality of well-trained clinical investigators.
     
  • Facilitate, through intensive mentoring, the transition fromscholar to independent clinical investigator
     
  • Bring City of Hope scientists and clinicians closer together to facilitate the bench-to-bedside continuum
     

CITP Core Curriculum

CITP Core Curriculum

Core Curriculum
The City of Hope Clinical Investigation Training Program (CITP) is a yearlong (4 quarter) curriculum designed to present the principles and practices used in the planning and execution of patient-oriented research including principles and methods in biostatistics, clinical epidemiology, clinical trial development, ethics, and good clinical practices of research. Each course can be taken in any order throughout the year. A certificate in Clinical Research is awarded to scholars successfully completing the Program.
 
Methodology in Observational Studies CI510 (Fall) - Design & Analysis of Observational Research
Provides an overview of epidemiologic methods and their application to observational studies. Scholars will develop/enhance their ability to evaluate observational studies, including the adequacy of study design and the validity of stated conclusions. Scholars will also acquire the necessary conceptual frameworkto plan an observational study in collaboration with a statistical co-investigator.
 
Methodology in Therapeutic Studies CI520 (Winter) - Design& Analysis of Intervention Research
Provides anintroduction to the concepts, theory, and application of interventional clinical trials and the statistics commonly used to analyze these studies. This is a Biostatistics/Clinical Investiagation course that builds on basic background of biostatistics, and introductory clinical trials. This course will explore the fundamentals of clinical investigation including: the definition of study goals, application and theory, objectives and outcomes, trial design and outcome monitoring, and result reporting, as well as a brief review of the underlying statistical methods.
 
Study Design & Development CI530 (Spring) - Design & Development of Human Subject Research
Provides a review of the clinical study process as well as continued instruction in trial development. Scholars will experience the "Nuts and Bolts" of a clinical study, from submission, to committee review, activation, and monitoring. Each scholar will actively participate in the submission of a "mock" clinical protocol. The proper design, conduct, and analysis of a clinical study are imperative to the well being of each participant as well as the integrity of the study results. Responsible conduct of research and good clinical practice will be emphasized throughout the course as they are the cornerstones to an effective and efficient clinical study.
 
Scientific Writing & Evaluation CI550/1 (Summer)
This course will alternate yearly, and address topics in protocol writing and development (CI550) and career development awards (CI551). The emphasis of CI550 will be on developing a complete and feasible protocol leading to an efficient, effective clinical study. The classes will combine didactic instruction with small group discussions and "hands on" learning. The emphasis of CI551 will be on early career advancement, competitivegrant writing, and literature evaluation. This course will focus on developing a fundable, career development award suitable for peer review. Evaluations will be through oral presentations and a completed career development application.
 

Contact Information

CITP Contact Information

Lina Mayorga, M.P.H., C.H.E.S.
Graduate Medical Educaton & Clinical Training
Direct: 626-218-8714
Education and Training
As one of only a select few National Cancer Institute-designated Comprehensive Cancer Centers in the country, City of Hope integrates all aspects of cancer research, treatment and education. We offer a range of programs serving students, post-doctoral trainees, health and medical professionals.

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Local and national conferences, in-depth educational training and a certification program provide both current and aspiring health professionals opportunities to further their knowledge in their fields of interest.
 
 
City of Hope offers a range of programs and services, such as Graduate Medical Education & Clinical Training, that serve students, post-doctoral trainees, medical professionals and staff.
The goal of the Postdoctoral Training Office is to ensure the postdoctoral experience at City of Hope is rewarding and meaningful to all participants.


NEWS & UPDATES
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...
  • In years past, Bladder Cancer Awareness Month has been a sobering reminder of a disease with few treatment options. For patients with metastatic disease (disease that has spread from the bladder to distant organs), average survival is typically just over one year. Fortunately, things are changing. Academic inst...
  • Tina Wang was diagnosed with Stage 4 diffuse large b cell lymphoma at age 22. She first sought treatment at her local hospital, undergoing two cycles of treatment. When the treatment failed to eradicate her cancer, she came to City of Hope. Here, Wang underwent an autologous stem cell transplant and participate...